Commission Regulation (EU) 2024/2633 of 8 October 2024 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, famoxadone, flutriafol, mandipropamid and mefentrifluconazole in or on certain products

Text

Article-level text, parsed from the formex manifestation.

Annex II to Regulation (EC) No 396/2005 is amended in accordance with the Annex to this Regulation.

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

What this act cites, and what cites it.

Point-in-time consolidated versions of this act.